Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli.

Παρόμοια τεκμήρια

• Multidrug resistant Gram-negative bacilli in lower respiratory tract infections
  ανά: Vishwanath, Shashidhar, κ.ά.
  Έκδοση: (2013)
• Is There Complete Cross-Resistance of Gram-Negative Bacilli to Gentamicin and Tobramycin?
  ανά: Crowe, C. C., κ.ά.
  Έκδοση: (1972)
• Bacteriological Profile and Antibiotic Susceptibility Patterns of Gram-negative Bacilli Isolated from Lower Respiratory Tract Infections
  ανά: Divya Atray, κ.ά.
  Έκδοση: (2023-01-01)
• In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli
  ανά: Fleischmann, Wim A., κ.ά.
  Έκδοση: (2020)
• Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli.
  ανά: Strandberg, D A, κ.ά.
  Έκδοση: (1983)